Lacaba, Baby Girl N.

HRN: 20-78-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2022
AMPICILLIN 250MG (VIAL)
07/31/2022
08/06/2022
IV
120mg
Q12
Potentially Septic Newborn
Waiting Final Action 
07/31/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/31/2022
08/06/2022
IV
10mg
Q24
Potentially Septic Newborn
Waiting Final Action 
08/06/2022
CEFTAZIDIME 1GM (VIAL)
08/06/2022
08/12/2022
IV
72
Q8H
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: